The Harry J Duffey Family Patient and Family Services Program at the Johns Hopkins Kimmel Cancer Center has compiled a list of events, activities, and resources available during the month of December. Sign up to be on our email list here. This month includes access to support groups, tips for holiday eating, access to transportation […]
Prevention/Screening
Smoking Cessation and Lung Cancer Screening
Posted by | Issues & Perspectives, Prevention/ScreeningDr Panagis Galiatsatos, Director of the Johns Hopkins Tobacco Treatment Clinic, speaks with Larry Young from News Radio 1010 WOLB about the importance of lung cancer screening and smoking cessation for lung cancer awareness month. Listen to the interview here. Click here for more information about the Johns Hopkins Tobacco Treatment and Cancer Screening […]
Kimmel in DC with Dr. Ashwani Rajput – Colorectal Cancer Surgery
Posted by | podcast, Prevention/ScreeningIn this Kimmel in DC podcast, Dr Ashwani Rajput and Dr Haniee Chung discuss the screening and surgical options for colorectal cancer. March is colorectal cancer awareness month, so remember to speak with your doctor about the right time to begin screening.
Cancer Matters with Dr. Bill Nelson – Trey Mancini
Posted by | Patient Stories, podcast, Prevention/ScreeningIn this Cancer Matters podcast, Johns Hopkins Kimmel Cancer Center Director Dr Bill Nelson speaks with Trey Mancini of the Baltimore Orioles and Dr Nilofer Azad about Trey's treatment, and return to baseball, following a diagnosis of colon cancer.
Great News for Lung Cancer Patients
Posted by | Issues & Perspectives, precision medicine, Prevention/Screening, Research, Survivorship, treatmentEach year, the American Cancer Society publishes data that gives a review of cancer statistics with foundational data that tells us about new cases in the U.S. and details on incidence and survival statistics state by state, overall and by cancer type. The latest report, which made headlines for a historic drop in cancer deaths, […]
Lung Cancer Expert Julie Brahmer Comments on Historic Decline in Cancer Deaths
Posted by | Issues & Perspectives, precision medicine, Prevention/Screening, SurvivorshipCancer death rates in the U.S. took the “biggest single-year drop ever,” according to a new report by the American Cancer Society. Improvements in the screening and treatment of lung cancer, the 2nd most common cancer and leading cancer killer, are a main contributor to this positive trend. Julie Brahmer, M.D., Director of the Kimmel […]
Helping Breast Cancer Survivors Reach Their Weight-Loss Goals
Posted by | Issues & Perspectives, precision medicine, Prevention/Screening, Research, SurvivorshipNumerous studies have shown that even a modest amount of weight loss can improve a variety of health-related metrics and quality of life for those who are overweight or obese. Attaining a healthy weight is important for breast cancer survivors, says new Kimmel Cancer Center breast cancer expert Jennifer Sheng, M.D. Studies have shown that […]
DELFI Blood Test: A Brand New Way of Detecting Multiple Cancers
Posted by | Prevention/ScreeningA new cancer test developed by Johns Hopkins Kimmel Cancer Center scientists screens for seven types of cancer in a completely unique way. DELFI is a new and different kind of cancer screening test. Rather than finding cancer gene mutations or chemical alterations to the DNA, known as epigenetic changes, it detects unique patterns in […]
The Future of Pancreatic Cancer Treatments
Posted by | Issues & Perspectives, pancreatic cancer, Prevention/Screening, Research, treatmentJust eight percent of people with pancreatic cancer live for five years after their diagnosis. Why is this cancer so deadly and where are advances in treatment headed? Elizabeth Jaffee, M.D., deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, describes explains in a 2018 interview on WYPR. http://www.wypr.org/post/why-pancreatic-cancer-so-deadly
Jaffee looks to the future of checkpoint immunotherapy for cancer treatment
Posted by | Issues & Perspectives, precision medicine, Prevention/Screening, treatmentCombinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important advances were also made with respect to immune-related biomarkers, cellular immunotherapies, and personalized vaccines. Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, is focusing her research […]